Maxrin D Capsule is indicated for:
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Maxrin D is a fixed-dose combination of Tamsulosin Hydrochloride and Dutasteride, two agents with complementary mechanisms that target both the dynamic and static components of BPH, leading to improved urinary flow and symptom relief.
Tamsulosin is a selective alpha-1 adrenergic receptor blocker that acts primarily on smooth muscle in the prostate and bladder neck. Inhibiting these receptors, it relaxes the prostatic and bladder neck smooth muscle, thereby reducing urinary obstruction and improving urine flow.
Tamsulosin shows selectivity for alpha-1A and alpha-1D receptor subtypes, which are predominantly located in the prostate and bladder. Blockade of these receptors is believed to reduce bladder overactivity and alleviate storage symptoms such as urgency and frequency, while minimizing vascular effects associated with alpha-1B receptor inhibition.
Dutasteride is a synthetic 4-azasteroid and a potent, competitive inhibitor of both Type I and Type II 5-alpha reductase isoenzymes. These enzymes are responsible for converting testosterone into dihydrotestosterone (DHT), the hormone that drives prostate enlargement.
By significantly reducing DHT levels, Dutasteride decreases prostate volume and addresses the underlying cause of BPH. It does not bind to androgen receptors and dissociates slowly from the enzyme complex, resulting in sustained suppression of DHT.
One capsule once daily, containing Tamsulosin Hydrochloride 0.4 mg and Dutasteride 0.5 mg
To be taken approximately 30 minutes after the same meal each day
Capsules should be swallowed whole and must not be chewed, crushed, or opened
This combination may be used to replace concomitant Dutasteride and Tamsulosin therapy to simplify treatment. Where clinically appropriate, patients may be switched directly from monotherapy to Maxrin D.
No dosage adjustment is expected, as pharmacokinetic effects have not been studied
Use with caution in mild to moderate hepatic impairment
Contraindicated in severe hepatic impairment
Women, children, and adolescents
Patients with hypersensitivity to Dutasteride, other 5-alpha reductase inhibitors, Tamsulosin, soya, peanut, or any excipients
History of orthostatic hypotension
Severe hepatic impairment
Combination therapy should be prescribed after careful benefit–risk assessment
Slightly increased risk of cardiac failure has been reported with long-term combination therapy
PSA levels decrease by ~50% after 6 months; a new PSA baseline should be established and monitored regularly
Orthostatic hypotension may occur; patients should be advised to sit or lie down if symptoms develop
Caution when co-administered with PDE-5 inhibitors
Risk of Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery; inform ophthalmologist prior to surgery
Leaking capsules should not be handled by women or children
Rare cases of male breast cancer have been reported; patients should report breast changes promptly
Contraindicated in women
Dutasteride may affect semen parameters; pthe otential impact on male fertility cannot be excluded
Exposure of pregnant women to Dutasteride (including via semen) may affect male fetal genital development
Male patients should use condoms if their partner is pregnant or may become pregnant
It is unknown whether Dutasteride or Tamsulosin is excreted in human milk
Metabolized primarily via CYP3A4 and CYP3A5
Concomitant use with CYP3A4 or P-glycoprotein inhibitors (e.g., verapamil, diltiazem) may increase Dutasteride serum levels
Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir) may further elevate exposure; dose frequency reduction may be considered if adverse effects occur
No significant interaction observed with warfarin, digoxin, or cholestyramine
Concurrent use with antihypertensives, PDE-5 inhibitors, anesthetics, or other alpha-blockers may enhance hypotensive effects
Use with cimetidine may increase Tamsulosin exposure; caution is advised
No clinically significant interactions reported with atenolol, enalapril, nifedipine, or theophylline
Diclofenac may increase the tamsulosin elimination rate
Store in a cool, dry place
Protect from light
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.